For those looking to lower stress levels this year, hitting the gym or a brisk walk might be the best strategy, especially ...

The EPA may soon stop assessing health benefits of cleaner air, which could lead to weaker protections against some of the most dangerous pollutants.

The CDC is scaling back several childhood vaccine recommendations, prompting concerns that fewer kids will be protected as a result.

A pulmonologist is sued after responding to a call from ICU staff to prevent airway collapse in a patient who was ultimately ...

The federal government has released new dietary guidelines that shift how Americans are urged to eat with a new focus on meat and dairy.

Transient receptor potential canonical channels are essential for maintaining the function of human pulmonary endothelial cells in PAH.

Underlying causes of recurrent pneumonia in children have changed in the last decade, indicating a need for individualized diagnostic approaches.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

Structural and functional pulmonary MRI measurements may predict future pulmonary exacerbations among individuals with cystic fibrosis.

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

Elexacaftor/tezacaftor/ivacaftor use is linked to long-term decreases in chronic respiratory therapies in patients with cystic fibrosis.

Individuals with a history of immune-mediated inflammatory diseases (IMIDs) may have a higher risk for sarcoidosis onset, a Japanese study found.